BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6947950)

  • 1. Hemostatic function tests associated with diabetic microangiopathy.
    Fuller JH
    Horm Metab Res Suppl; 1981; 11():59-62. PubMed ID: 6947950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic variables associated with diabetes and its complications.
    Fuller JH; Keen H; Jarrett RJ; Omer T; Meade TW; Chakrabarti R; North WR; Stirling Y
    Br Med J; 1979 Oct; 2(6196):964-6. PubMed ID: 509177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Int Angiol; 1986; 5(3):181-95. PubMed ID: 3104511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic retinopathy and the fibrinolytic system.
    Almér LO; Pandolfi M; Nilsson IM
    Diabetes; 1975 Jun; 24(6):529-34. PubMed ID: 49282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
    Breddin HK; Krzywanek HJ; Althoff P; Schöffling K; Uberla K
    Horm Metab Res Suppl; 1985; 15():63-8. PubMed ID: 2934312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
    Gargiulo P; Schiaffini R; Bosco D; Ciampalini P; Pantaleo A; Romani B; Arcieri P; Andreani D
    Diabet Med; 1997 Feb; 14(2):132-7. PubMed ID: 9047090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of rheological factors on diabetic microangiopathies: is there an effective medical treatment for diabetic retinopathy?].
    Meunier I; Soubrane G; Coscas G
    Bull Soc Belge Ophtalmol; 1995; 256():67-70. PubMed ID: 8581233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
    Kostić N; Secen S
    Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis and diabetic retinopathy.
    Almér LA; Pandolfi M
    Diabetes; 1976; 25(2 SUPPL):807-10. PubMed ID: 61139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.
    Santamaría A; Borrell M; Oliver A; Ortín R; Forner R; Coll I; Mateo J; Souto JC; Fontcuberta J
    Am J Hematol; 2004 Aug; 76(4):348-52. PubMed ID: 15282667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Klin Wochenschr; 1986 Oct; 64(20):1042-6. PubMed ID: 3491249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
    Kohriyama T; Katayama S; Tanaka E; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostasis in diabetics.
    Misz M; Beck P; Udvardy M; Rák K
    Acta Med Hung; 1984; 41(2-3):93-102. PubMed ID: 6235479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH
    Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation and fibrinolysis are in balance after moderate exercise in middle-aged participants.
    Menzel K; Hilberg T
    Clin Appl Thromb Hemost; 2009; 15(3):348-55. PubMed ID: 19022797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.